Global MRI Horizon: Market Structure, Forecasts, and AI Monetization Architecture (2024A–2035E)

Publisher MarketStrat, Inc.

Published Feb 18, 2026

Length 295 Pages

SKU # MS20886587

Description

This Horizon report is Marketstrat’s in depth global analysis of the MRI market—built for MRI OEM executives, strategy and corporate development teams, services/aftermarket leaders, investors, provider procurement/operations, and AI/platform vendors adjacent to MRI.

Unlike conventional MRI market reports, this Horizon report treats AI as a monetization architecture (embedded vs recurring attach vs consumption/PPU vs services) and links it directly to throughput economics, upgrades, workflow governance, and enterprise procurement behavior.

The study provides reconciled forecasts by standardized geographies (North America, Europe, APAC, Latin America, Middle East & Africa) and country-level rollups (US, Canada, Germany, France, UK, Italy, Rest of Europe, China, Japan, India, Rest of APAC, LATAM, MEA).

Marketstrat organizes the competitive landscape into ecosystem clusters (systems OEMs; AI reconstruction; workflow/orchestration; quantitative/post-processing; platforms; service/aftermarket; suppliers/subsystems) and applies the Markintel™ framework stack—M³ Market Momentum, M‑TEM technology maturity scoring, T‑DIC diffusion curve, Solution Adoption & Growth Matrix, Use‑Case Monetization Map, ARC‑Index, Ecosystem Collaboration Matrix + Partnering Decision Tree, and the Upgrade & Package Ladder—to translate market sizing into actionable strategy and GTM implications.

Key Takeaways

The global MRI ecosystem (systems + service/aftermarket + AI recurring software) expands from ~$15.1B (2024A) to ~$25.1B (2035E), with growth increasingly driven by mix, upgrades, and commercialization architecture, not unit volume alone.
MRI is entering a structural mix transition: premiumization (3T adoption and upgrade cycles) accelerates while low field expands in access driven settings, reshaping “what wins” by end market and geography.
The AI layer is not a feature checklist—it is a monetization shift: what starts as console native differentiation increasingly moves toward attach subscriptions, enterprise standardization, and consumption economics (cloud/PPU + managed services) as workflow orchestration becomes the control point.

MRI remains one of the most strategically important imaging modalities because it sits at the intersection of high clinical value, complex operations, and long lived installed base economics. Over the horizon, MRI growth is increasingly mix led: premium tiers, upgrade cycles, software/AI packaging, and service lifecycle monetization drive value capture more than unit shipment growth.

A second structural shift is underway: MRI economics are becoming more explicitly tied to workflow plane control—protocol standardization, automation/QC (“first time right”), routing, and remote scanning enablement—rather than scanner performance alone. This is also where AI monetization shifts from embedded value to attach + enterprise + consumption models.

Company Spotlights

Affidea; AGFA HealthCare; Aidoc; Air Liquide; Air Products; AIRS Medical; Alliance Medical; Amazon Web Services (AWS); Amuneal; Analog Devices; Avante Health Solutions; Bayer; Blackford Analysis; Block Imaging; Bracco; Bruker; Canon Medical Systems; Circle Cardiovascular Imaging; Cortechs.ai; Cryomech; EnvoyAI; Epic; Esaote; ETS-Lindgren; Flywheel; Fujifilm (Synapse); Fujifilm Healthcare (incl. Hitachi legacy); Furukawa Electric; GE HealthCare; Google Cloud; Guerbet; Hyland; Hyperfine; Icometrix; InHealth; Integrity Imaging; Intelerad; Japan Superconductor Technology (JASTEC); Kopp Development; LeanTaaS; Linde; Mach7 Technologies; MediGlobe; Medis Medical Imaging; Metrasens; Microsoft (Azure); Nemoto Kyorindo; Neusoft Medical; NORAS MRI products; Nuance (Microsoft); Oracle Cerner; Paramed Medical Systems; PartsSource; Perspectum; Philips; Philips (IntelliSpace); Pneumacoustics (Serene Sound); Pro Medicus (Visage); Promaxo; Quibim; Qure.ai; Qynapse; Radiology Partners; RadNet; RadNet (DeepHealth); RAPID Biomedical; Sectra; Shared Medical Services (SMS); Siemens Healthineers; Soma Tech Intl; Subtle Medical; Sumitomo Electric Industries; Sumitomo Heavy Industries (SHI); SyntheticMR; Texas Instruments; Time Medical; ulrich medical; United Imaging Healthcare; Vista.ai (Formerly HeatVista); Viz.ai; vRad (Virtual Radiologic); Wandong Medical.

Intended Audience

This report is designed for decision-makers with product, commercial, operational, or capital exposure to MRI, including:

Imaging OEM executives (strategy, product, services, corporate development)
AI reconstruction, workflow/orchestration, and quantitative MRI vendors
Enterprise imaging platform vendors and cloud/marketplace players
Provider procurement, radiology operations, and IDN leadership
Investors, banks, and private equity evaluating consolidation and value capture paths
Suppliers and ecosystem partners exposed to MRI siting, cryogenics, shielding, coils, accessories, and contrast/injectors.

Report Details

Title: Global MRI Horizon: Market Structure, Forecasts, and AI Monetization Architecture (2024A–2035E)
Type: Markintel™ Horizon (Flagship, In Depth)
Publication: February 2026
Length: ~296 pages (111 market data tables, 86 figures including strategic frameworks)

Geographical Coverage:

North America (US, Canada) | Europe (Germany, France, UK, Italy, ROE) | APAC (China, Japan, India, ROAPAC) | LATAM | MEA
Market Segmentation (core + analytical cuts):
Systems segmentation (field-strength tiers)
Ecosystem revenue streams (systems, service/aftermarket, AI recurring; AI bridge value pools)
End-market, clinical application, purchase model, operating model
AI capability layer (recon/accel, motion/QC, protocol automation, orchestration, quantitative MRI)

SECTION 1 – EXECUTIVE SUMMARY: 1.1 EXECUTIVE TAKEAWAYS; 1.2 EXECUTIVE SUMMARY DASHBOARD; 1.3 GLOBAL MARKET AT-A-GLANCE (CORE MODEL); 1.4 THE AI LAYER: WHERE MONETIZATION SHIFTS (BRIDGE VIEW); 1.5 MARKET STRUCTURE: WHAT IS STRUCTURALLY CHANGING; 1.6 IMPLICATIONS-TO-ACTION (EXECUTIVE ACTIONS); 1.7 SIGNALS TO WATCH (NEXT 12–24 MONTHS)
SECTION 2 - RESEARCH & METHODOLOGY: 2.1 WHAT THIS REPORT IS—AND WHAT IT IS NOT; 2.2 RESEARCH FOUNDATION AND HOW SOURCES ARE USED; Source Inputs (Triangulation Base); Evidence Handling and Defensibility; 2.3 METHODOLOGY ARCHITECTURE – MARKINTEL HORIZON PROGRAM (MRI); 2.4 MARKET DEFINITION AND SEGMENTATION SCHEMA; What Is Included in the Modeled “MRI Ecosystem”; Systems Segmentation; Geography Standardization; 2.5 RESEARCH WORKFLOW – MARKINTEL HORIZON PROGRAM (MRI); 2.6 CORE MARKET SIZING & FORECASTING METHODOLOGY (2024A–2035E); Core Quantities Forecasted; How The Model Is Constructed (In Plain Language); Outputs Designed for Publishing; 2.7 AI LAYER METHODOLOGY: CORE RECURRING VS TOTAL AI BRIDGE; “Core AI Recurring” (Inside Ecosystem Totals); “AI Bridge” (Total MRI AI Value Pool by Stream); 2.8 NON-MODEL ANALYTICAL CUTS METHODOLOGY; Allocation + Reconciliation Approach; Publishable Outputs; 2.9 COMPETITIVE LANDSCAPE METHODOLOGY; Company Universe and Clustering; Placement Logic and Evidence Flags; Company Spotlights; 2.10 STRATEGIC FRAMEWORKS: HOW MARKINTEL IS USED; 2.11 QA, RECONCILIATION, AND REPRODUCIBILITY; 2.12 LIMITATIONS AND GUIDANCE FOR INTERPRETATION
SECTION 3 - STRATEGIC FRAMEWORKS/MARKET STRUCTURE: 3.1 WORLD MRI MARKET OVERVIEW (MODELED CORE); Global MRI Market — Core Overview (Modeled Core, Base Case); Global MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; Global MRI Unit Shipments by Segment or System Type (2024A, 2035E); Global MRI Systems Market by Segment or System Type (2024A, 2035E, USD $M); Global MRI Systems Installed Base by Segment or System Type (Units, 2024A, 2035E); 3.2 WORLD MRI MARKET — NON-MODEL ANALYSIS (ANALYTICAL CUTS); Methodology Note (Allocation + Reconciliation); Global MRI Market by End-Market (Provider Setting); What the Table Shows; Key Mix Shifts (2024A → 2035E); What’s Driving the Shift; Commercial Implications; Global MRI Market by Clinical Application (Service-Line / Anatomy Mix); Key Mix Shifts (2024A → 2035E); What’s Driving the Shift; Commercial Implications; Global MRI Market by Purchase Model Mix (Procurement / Financing Structure); Key Mix Shifts (2024A → 2035E); What’s Driving the Shift; Commercial Implications; Global MRI Market by Operating Model Mix (Delivery & Staffing Structure) + Remote Scanning Overlay; Key Mix Shifts (2024A → 2035E); What’s Driving the Shift; Commercial Implications; Global MRI Market by AI Layer Mix (Capability Category) — Recurring Revenue Mix; Key Mix Shifts (2024A → 2035E); What’s Driving the Shift; Commercial Implications; 3.3 STRATEGIC FRAMEWORKS ARCHITECTURE – MRI HORIZON PROGRAM; Strategic Frameworks / Market Structure — How the Framework Stack Works; Market / Segment Structure: “Where to Play, And How Fast Is It Moving?”; Competitive / Ecosystem: “Who Wins, And What Partnerships Are Structurally Required?”; Commercial / Monetization: “How Is Value Packaged, Priced, And Captured?”; 3.4 M³ MARKET MOMENTUM MATRIX (GLOBAL MRI); M³ Market Momentum Matrix — MRI System Segments; Segment Momentum Snapshot — MRI System Segments; M³ Market Momentum Matrix — MRI Ecosystem Revenue Streams; Segment Momentum Snapshot — MRI Ecosystem Revenue Streams; Strategic Takeaways - M³ Market Momentum Matrix (Global MRI); 3.5 M-TEM (TECHNOLOGY MATURITY SCORING); Evidence-based Observations; Marketstrat Interpretation; M-TEM Scorecard Table; Strategic Implication for Commercialization; 3.6 MRI AI REVENUE BY STREAM (BRIDGE); Defining the Hybrid PPU Model; Key Quantitative Takeaways (Base Case); Commercial Interpretation (what this revenue stream bridge means); 3.7 T‑DIC (TECHNOLOGY DIFFUSION & IMPACT CURVE); Technology Diffusion & Shifts; Implications by Stakeholder; T-DIC Technology Table; 3.8 SOLUTION ADOPTION & GROWTH MATRIX; Implications by Stakeholder; MRI AI Use Cases – Definitions, Adoption/Growth Positioning; Definitions; Commercialization Logic Embedded in The Table; Limitations / Assumptions; 3.9 MRI AI USE CASE MONETIZATION MAP; Definitions, Adoption/Growth Positioning, Monetization Posture, and Adoption Gating Themes; 3.10 GTM GROWTH–MATURITY MATRIX — MRI ECOSYSTEM (SELECTED); Competitive Dataset — Growth Outlook vs. GTM Maturity (MRI ecosystem); Why/How Companies Are Placed Here; 3.11 ECOSYSTEM COLLABORATION – MRI ECOSYSTEM; Ecosystem Collaboration Matrix; Ecosystem Collaboration Control Panes; Control Pane Map; Practical Implications for Competitive Dynamics; MRI: Partnership Archetypes and Control-Plane Owners; Collaboration Playbook — MRI AI Ecosystem; KPI Contracting Template; Monetization Alignment; Partnering Decision Tree; 3.12 ARC-INDEX (APPROVALS, REIMBURSEMENT, CLINICAL VALIDATION); ARC-Index and Packaging Implications; High ARC (Scale-Ready); Medium ARC (Scaling with Gating); Emerging ARC (Selective/Pilots); ARC-to-Commercial Motion Cheat Rules; 3.13 MRI UPGRADE & PACKAGE LADDER; Service Portfolio Evolution; How OEMs Monetize Upgrades vs Bundles vs Enterprise Agreements (Practical Rules); 3.14 MRI AI REVENUE BRIDGE; What The AI Revenue Bridge Is Telling Us; How The Upgrade & Package Ladder Drives the Revenue Bridge; Commercial Implications (What This Means for Packaging Strategy)
SECTION 4 - COMPETITIVE LANDSCAPE — CLUSTER-BASED VIEW OF THE MRI ECOSYSTEM: 4.1 CROSS-CUTTING COMPETITIVE THESIS; 4.2 COMPETITIVE LANDSCAPE MAP – MRI ECOSYSTEM (CLUSTERS & SUBCLUSTERS); Global MRI Systems — OEM Share Bands (2024A, Global); Definition (Important Qualifiers); How To Use These Share Bands (Recommended Interpretation); Implications (Why This Matters Commercially); Competitive Signal Scorecard (Selected High-Impact Companies; Banded); About This Scorecard; How the Competitive Signal Scorecard Ties to Moat; How To Read the Scorecard (Practical Interpretation); What This Table Is Used for In The Report; Limitations and Guardrails; 4.3 CLUSTER 1 — SYSTEMS OEMS; Cluster Landscape (How Competition Works); Monetization Posture (OEM Archetype); Signals to Watch (Next 12–24 Months); Company Spotlights (Systems OEMs – MRI Hardware); Siemens Healthineers; GE HealthCare; Philips; United Imaging Healthcare; Canon Medical Systems; Fujifilm Healthcare (incl. Hitachi legacy); Esaote; Bruker; Hyperfine; Promaxo; Neusoft Medical; Wandong Medical; Time Medical; Paramed Medical Systems; 4.4 CLUSTER 2 — AI RECONSTRUCTION & ACCELERATION; Cluster Landscape (How Competition Works); Monetization Posture; Signals to Watch; Company Spotlights (AI Reconstruction); AIRS Medical; Subtle Medical; Vista.ai (Formerly HeartVista); 4.5 CLUSTER 3 — WORKFLOW, AUTOMATION & ORCHESTRATION; Cluster Landscape (How Competition Works); Monetization Posture; Signals to Watch; Company Spotlights (Workflow/Orchestration); Nuance (Microsoft); Aidoc; Viz.ai; RadNet (DeepHealth); Qure.ai; Blackford Analysis; EnvoyAI; LeanTaaS; 4.6 CLUSTER 4 — QUANTITATIVE MRI & POST-PROCESSING; Cluster Landscape (How Competition Works); Monetization Posture; Signals to Watch; Company Spotlights (Quantitative/Post-Processing); SyntheticMR; Quibim; Perspectum; Icometrix; Circle Cardiovascular Imaging; Medis Medical Imaging; Flywheel; Cortechs.ai; Qynapse; 4.7 CLUSTER 5 — IMAGING IT & PLATFORMS; Cluster Landscape (How Competition Works); Monetization Posture; Signals To Watch; Company Spotlights (Platforms); Pro Medicus (Visage); Sectra; Fujifilm (Synapse); Philips (IntelliSpace); AGFA HealthCare; Intelerad; Mach7 Technologies; Hyland; Epic; Oracle Cerner; HYPERSCALERS (CLOUD SUBSTRATE FOR IMAGING AND AI); Amazon Web Services (AWS); Microsoft (Azure); Google Cloud; 4.8 CLUSTER 6 — SERVICE & AFTERMARKET; Cluster Landscape (How Competition Works); Monetization Posture; Signals To Watch; Company Spotlights (ISOs/Servies); Block Imaging; PartsSource; Alliance Medical; Shared Medical Services (SMS; Avante Health Solutions; Integrity Imaging; Soma Tech Intl; 4.9 CLUSTER 7 — SUPPLIERS & SUBSYSTEMS; Cluster Landscape (How Competition Works); Monetization Posture; Signals To Watch; COMPANY SPOTLIGHTS – CRYOGENICS; Cryomech; Sumitomo Heavy Industries (SHI); COMPANY SPOTLIGHTS – HELIUM / INDUSTRIAL GASES (SUPPLY DEPENDENCY LAYER); Air Liquide; Linde; Air Products; COMPANY SPOTLIGHTS – SHIELDING / SITING / RF INFRASTRUCTURE; ETS-Lindgren; Amuneal; COMPANY SPOTLIGHTS – SUPERCONDUCTING WIRE / MAGNET COMPONENT SUPPLY; Sumitomo Electric Industries; Furukawa Electric; Japan Superconductor Technology (JASTEC); COMPANY SPOTLIGHTS – ELECTRONICS / SEMICONDUCTORS (ENABLING LAYER); Analog Devices; Texas Instruments; COMPANY SPOTLIGHTS – MRI SAFETY / ACCESS CONTROL / DETECTION; Metrasens; Kopp Development; COMPANY SPOTLIGHTS – COILS & ACCESSORIES; RAPID Biomedical; NORAS MRI products; MediGlobe; Pneumacoustics (Serene Sound); COMPANY SPOTLIGHTS – CONTRAST & INJECTORS; Bayer; Bracco; Guerbet; Nemoto Kyorindo; ulrich medical; COMPANY SPOTLIGHTS – ADJACENT PROVIDERS & OPERATORS; RadNet; Affidea; InHealth; Radiology Partners; vRad (Virtual Radiologic)
SECTION 5 - MARKET ANALYSIS BY REGION/COUNTRY: 5.1 NORTH AMERICAN MRI MARKET; North America — Market Landscape (MRI Systems + Service + AI Layer); MRI Ecosystem Revenue Forecast; What Is Structurally Different About North America (vs. Other Regions); Technology And Product Strategy Themes That Matter in North America; Competitive and GTM dynamics (region level); North America MRI Market Estimates and Forecasts; North America MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; North America MRI System Segment Mix — Unit Shipments; North America MRI System Segment Mix — Systems Revenue; North America MRI System Segment Mix — Installed Base (End-of-Year Units); North America MRI Country Mix — Unit Shipments; North America MRI Country Mix — Systems Revenue; North America MRI Country Mix — Ecosystem Revenue; North America MRI Market — Non-Model Analysis (Analytical Cuts); North America MRI Market by End-Market (Provider Setting); North America MRI Market by Clinical Application (Service-Line/Anatomy Mix); North America MRI Market by Purchase Model Mix (Procurement / Financing Structure); North America MRI Market by Operating Model Mix (Delivery & Staffing Structure) + Remote Scanning Overlay; North America MRI Market by AI Layer Mix (Capability Category) – Recurring Revenue Mix; 5.2 UNITED STATES MRI MARKET; US Market Landscape; Market Snapshot; MRI Ecosystem Revenue Forecast; Demand and Utilization Economics; Fleet Age and Replacement Cycle; Technology Mix Shift; AI Layer in the US; Competitive and Commercial Dynamics (US lens); Signals to Watch (Next 12–24 Months; US); US MRI Market Estimates and Forecasts; US MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; US MRI System Segment Mix — Unit Shipments; US MRI System Segment Mix — Systems Revenue; US MRI System Segment Mix — Installed Base (End-of-Year Units); US MRI Market Structure Snapshot – Analytical Cuts (2024A vs 2035E); 5.3 CANADIAN MRI MARKET; Canadian Market Landscape; Market Snapshot; MRI Ecosystem Revenue Forecast; Demand and System Economics; Mix Shift; Technology and Siting; AI Layer; Competitive Dynamics; Signals to Watch (Next 12–24 Months; Canada); Canada MRI Market Estimates & Forecasts; Canada MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; Canada MRI System Segment Mix — Unit Shipments; Canada MRI System Segment Mix — Systems Revenue; Canada MRI System Segment Mix — Installed Base (End-of-Year Units); Canada MRI Market Structure Snapshot – Analytical Cuts (2024A vs 2035E); What the Dashboard Shows; Implications; 5.4 EUROPEAN MRI MARKET; Europe Market Landscape; Market Snapshot; MRI Ecosystem Revenue Forecast; Region Structure and Demand Clusters (Europe); Procurement and GTM Realities (Europe); Technology Mix Shift (Europe); AI Layer (Europe): Adoption Gating and Monetization Logic; Signals to Watch (Next 12–24 Months; Europe); Europe MRI Market Estimates and Forecasts; Europe MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; Europe MRI System Segment Mix — Unit Shipments; Europe MRI System Segment Mix — Systems Revenue; Europe MRI System Segment Mix — Installed Base (End-of-Year Units); Europe MRI Country Mix — Unit Shipments; Europe MRI Country Mix — Systems Revenue; Europe MRI Country Mix — Ecosystem Revenue; Europe MRI Market – Non-Model Analysis (Analytical Cuts); Europe MRI Market by End-Market (Provider Setting); Europe MRI Market by Clinical Application (Service-Line / Anatomy Mix); Europe MRI Market by Purchase Model Mix (Procurement / Financing Structure); Europe MRI Market by Operating Model (Delivery & Staffing Structure) + Remote Scanning Overlay; Europe MRI Market by AI Layer Mix (Capability Category) – Recurring Revenue Mix; 5.5 GERMAN MRI MARKET; Germany Market Landscape; Market Snapshot; MRI Ecosystem Revenue Forecast; Demand and Utilization Economics; Fleet Age and Replacement Cycle; Technology Mix Shift; AI Layer in Germany; Competitive and Commercial Dynamics (Germany Lens); Signals to Watch (Next 12–24 Months; Germany); Germany MRI Market Estimates & Forecasts; Germany MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; Germany MRI Unit Shipments by System Segment; Germany MRI Systems Revenue by System Segment; Germany MRI Installed Base by System Segment; Germany MRI Market Structure Snapshot – Analytical Cuts (2024A vs 2035E); What the Dashboard Shows; Implications; 5.6 FRENCH MRI MARKET; France Market Landscape; Market Snapshot; MRI Ecosystem Revenue Forecast; Demand and Utilization Economics; Fleet Age and Replacement Cycle; Technology Mix Shift; AI Layer in France; Competitive and Commercial Dynamics (France lens); Signals to Watch (Next 12–24 Months; France); France MRI Market Estimates & Forecasts; France MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; France MRI Unit Shipments by System Segment; France MRI Systems Revenue by System Segment; France MRI Installed Base by System Segment; France MRI Market Structure Snapshot – Analytical Cuts (2024A vs 2035E); What the Dashboard Shows; Implications; 5.7 UK MRI MARKET; UK Market Landscape; Market Snapshot; MRI Ecosystem Revenue Forecast; Demand and Utilization Economics; Fleet Age and Replacement Cycle; Technology Mix Shift; AI Layer in the UK; Competitive and Commercial Dynamics (UK lens); Signals to Watch (Next 12–24 Months; UK); UK MRI Market Estimates & Forecasts; UK MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; UK MRI Unit Shipments by System Segment; UK MRI Systems Revenue by System Segment; UK MRI Installed Base by System Segment; UK MRI Market Structure Snapshot – Analytical Cuts (2024A vs 2035E); What the Dashboard Shows; Implications; 5.8 ITALIAN MRI MARKET; Italy Market Landscape; Market Snapshot; MRI Ecosystem Revenue Forecast; Demand and System Economics; Fleet Age and Replacement Cycle; Technology Mix Shift; AI Layer in Italy; Competitive and Commercial Dynamics (Italy lens); Signals to Watch (Next 12–24 Months; Italy); Italy MRI Market Estimates & Forecasts; Italy MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; Italy MRI Unit Shipments by System Segment; Italy MRI Systems Revenue by System Segment; Italy MRI Installed Base by System Segment; Italy MRI Market Structure Snapshot – Analytical Cuts (2024A vs 2035E); What the Dashboard Shows; Implications; 5.9 ROE (REST OF EUROPE) MRI MARKET; ROE Market Landscape; Market Snapshot; MRI Ecosystem Revenue Forecast; Demand and Utilization Economics; Fleet Age and Replacement Cycle; Technology Mix Shift; AI Layer in ROE; Competitive and Commercial Dynamics (ROE lens); Signals to Watch (Next 12–24 Months; ROE); ROE MRI Market Estimates & Forecasts; ROE MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; ROE MRI Unit Shipments by System Segment; ROE MRI Systems Revenue by System Segment; ROE MRI Installed Base by System Segment; ROE MRI Market Structure Snapshot – Analytical Cuts (2024A vs 2035E); What the Dashboard Shows; Implications; 5.10 APAC MRI MARKET; APAC Market Landscape; Market Snapshot (Marketstrat base-case estimates; USD millions); Evidence-based observations (what is structurally true in APAC); Marketstrat interpretation (so what / implications); MRI Ecosystem Revenue Forecast; APAC MRI Market Estimates and Forecasts; APAC MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; APAC MRI System Segment Mix — Unit Shipments; APAC MRI System Segment Mix — Systems Revenue; APAC MRI System Segment Mix — Installed Base (End-of-Year Units); APAC MRI Country Mix — Unit Shipments; APAC MRI Country Mix — Systems Revenue; APAC MRI Country Mix — Ecosystem Revenue; APAC MRI Market – Non-Model Analysis (Analytical Cuts); APAC MRI Market by End-Market (Provider Setting); APAC MRI Market by Clinical Application (Service-Line / Anatomy Mix); APAC MRI Market by Purchase Model Mix (Procurement / Financing Structure); APAC MRI Market by Operating Model (Delivery & Staffing Structure) + Remote Scanning Overlay; APAC MRI Market by AI Layer Mix (Capability Category) – Recurring Revenue Mix; 5.11 CHINESE MRI MARKET; China Market Landscape; Market Snapshot; MRI Ecosystem Revenue Forecast; Demand and System Economics; Policy, Procurement, and Pricing Environment; Market Dynamics Update; Fleet Age and Replacement Dynamics; China MRI Market Risk Scenarios (2026-2030); Mix Shift; Technology and Siting; AI Layer; Competitive Dynamics; Signals to Watch (Next 12–24 Months; China); China MRI Market Estimates & Forecasts; China MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; China MRI Unit Shipments by System Segment; China MRI Systems Revenue by System Segment; China MRI Installed Base by System Segment; China MRI Market Structure Snapshot – Analytical Cuts (2024A vs 2035E); What the Dashboard Shows; Implications; 5.12 JAPANESE MRI MARKET; Japan Market Landscape; Market Snapshot; MRI Ecosystem Revenue Forecast; Demand & Utilization Economics; Clinical Catalysts; AI Layer in Japan; Competitive and Commercial Dynamics (Japan Lens); Japan MRI Market Estimates & Forecasts; Japan MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; Japan MRI Unit Shipments by System Segment; Japan MRI Systems Revenue by System Segment; Japan MRI Installed Base by System Segment; Japan - MRI Market Structure Snapshot - Analytical Cuts (2024A vs 2035E; What the Dashboard Shows; Implications; 5.13 INDIAN MRI MARKET; India Market Landscape; Market Snapshot; MRI Ecosystem Revenue Forecast; Demand and System Economics; Fleet Age and Replacement Cycle; Technology Mix Shift (Field Strength and Tiering); AI Layer in India; Competitive and Commercial Dynamics (India Lens); Signals to Watch (Next 12–24 Months; India); India MRI Market Estimates & Forecasts; India MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; India MRI Unit Shipments by System Segment; India MRI Systems Revenue by System Segment; India MRI Installed Base by System Segment; India - MRI Market Structure Snapshot - Analytical Cuts (2024A vs 2035E); What the Dashboard Shows; Implications; 5.14 ROAPAC (REST OF ASIA-PACIFIC) MRI MARKET; ROAPAC Market Landscape; Market Snapshot; MRI Ecosystem Revenue Forecast; Regional Cluster Lens (How to Read ROAPAC); Demand and Utilization Economics; Fleet Age and Replacement Cycle; Technology Mix Shift; AI Layer in ROAPAC; Competitive and Commercial Dynamics (ROAPAC lens); Signals to Watch (Next 12–24 Months; ROAPAC); ROAPAC MRI Market Estimates & Forecasts; ROAPAC MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; ROAPAC MRI Unit Shipments by System Segment; ROAPAC MRI Systems Revenue by System Segment; ROAPAC MRI Installed Base by System Segment; ROAPAC - MRI Market Structure Snapshot - Analytical Cuts (2024A vs 2035E); What the Dashboard Shows; Implications; 5.15 LATAM MRI MARKET; LATAM Market Landscape; Market Snapshot; MRI Ecosystem Revenue Forecast; Regional clusters (LATAM is not one market); What Structurally Drives LATAM MRI Economics; LATAM MRI Market Estimates & Forecasts; LATAM MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; LATAM MRI Unit Shipments by System Segment; LATAM MRI Systems Revenue by System Segment; LATAM MRI Installed Base by System Segment; LATAM - MRI Market Structure Snapshot - Analytical Cuts (2024A vs 2035E); What the Dashboard Shows; Implications; 5.16 MEA (MIDDLE EAST & AFRICA) MRI MARKET; MEA Market Landscape; MEA Cluster Structure (How to Read This Geography); What Makes MEA Structurally Different vs. OECD Markets (Commercial + Operational Realities); 12–24 Month Signals to Watch (MEA-specific); MEA MRI Market Estimates & Forecasts; MEA MRI Market Summary: Unit Shipments, Installed Base, and Ecosystem Revenue by Stream; MEA MRI Unit Shipments by System Segment; MEA MRI Systems Revenue by System Segment; MEA MRI Installed Base by System Segment; MEA - MRI Market Structure Snapshot - Analytical Cuts (2024A vs 2035E); What the Dashboard Shows; Implications
LIST OF FIGURES: FIGURE 1: EXECUTIVE SUMMARY DASHBOARD — GLOBAL MRI MARKET & AI LAYER (2024A–2035E, BASE CASE); FIGURE 2: METHODOLOGY ARCHITECTURE — MARKINTEL HORIZON PROGRAM (MRI); FIGURE 3: RESEARCH WORKFLOW — MARKINTEL HORIZON PROGRAM (MRI); FIGURE 4: GLOBAL MRI ECOSYSTEM REVENUE FORECAST — SYSTEMS, SERVICE, AND AI RECURRING (2024A–2035E, BASE CASE); FIGURE 5: GLOBAL MRI END-MARKET MIX – ECOSYSTEM REVENUE GROWTH BRIDGE (2024A  2032E, $M); FIGURE 6: GLOBAL MRI END-MARKET MIX – SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 7: GLOBAL MRI CLINICAL APPLICATION MIX – ECOSYSTEM REVENUE GROWTH BRIDGE (2024A VS 2035E, $M); FIGURE 8: GLOBAL MRI CLINICAL APPLICATION MIX – SHARE CHANGE (PP): 2035 VS 2024A; FIGURE 9: GLOBAL MRI PURCHASE MODEL – SYSTEMS REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 10: GLOBAL MRI PURCHASE MODEL – SYSTEMS REVENUE SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 11: GLOBAL MRI OPERATING MODEL – SYSTEMS REVENUE GROWTH BRIDGE: 2024A TO 2035E); FIGURE 12: GLOBAL MRI OPERATING MODEL – SERVICE REVENUE SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 13: GLOBAL MRI AI LAYER – RECURRING REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 14: GLOBAL MRI AI LAYER – RECURRING REVENUE SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 15: STRATEGIC FRAMEWORKS ARCHITECTURE — MRI HORIZON REPORT (SPRINT A/B/C FRAMEWORK STACK AND LINKAGES); FIGURE 16: M³ MARKET MOMENTUM MATRIX — MRI SYSTEM SEGMENTS (2024 SYSTEMS REVENUE VS. 2024–2035 CAGR); FIGURE 17: M³ MARKET MOMENTUM MATRIX — MRI ECOSYSTEM REVENUE STREAMS (2024 REVENUE VS. 2024–2035 CAGR); FIGURE 18: MARKINTEL M-TEM (TECHNOLOGY EVOLUTION MATRIX) – MRI TECHNOLOGY STACK; FIGURE 19: GLOBAL MRI AI REVENUE BY REVENUE STREAM (BRIDGE) — BASE CASE (USD $M, 2024A–2035E); FIGURE 20: MARKINTEL T‑DIC (TECHNOLOGY DIFFUSION & IMPACT CURVE) — MRI: PRIORITY TECHNOLOGY TRANSITIONS; FIGURE 21: MARKINTEL SOLUTION ADOPTION & GROWTH MATRIX — MRI AI USE CASES (CURRENT ADOPTION VS FUTURE GROWTH POTENTIAL); FIGURE 22: USE-CASE MONETIZATION MAP – MRI AI LAYER (HOW VALUE IS PACKAGED AND WHO BUYS); FIGURE 23: MARKINTEL GTM GROWTH–MATURITY MATRIX — MRI ECOSYSTEM (SELECTED); FIGURE 24: MARKINTEL ECOSYSTEM COLLABORATION MATRIX — MRI (GLOBAL): STRATEGIC VALUE VS COLLABORATION DEPTH; FIGURE 25: MARKINTEL ECOSYSTEM COLLABORATION MATRIX — MRI: CONTROL PLANE MAP (DISTRIBUTION VS WORKFLOW) ANDPARTNERSHIP DEPENDENCIES; FIGURE 26: MARKINTEL PARTNERING DECISION TREE — MRI AI LAYER (CONTROL PLANE GAPS - PARTNERSHIP ARCHETYPE - MONETIZATION MODEL); FIGURE 27: ARC INDEX SCORECARD — MRI AI CAPABILITIES (APPROVALS / REIMBURSEMENT READINESS / CLINICAL VALIDATION); FIGURE 28: MARKINTEL MRI UPGRADE & PACKAGE LADDER — SYSTEMS + AI + SERVICE MONETIZATION (OEM COMMERCIALIZATION PATH); FIGURE 29: COMPETITIVE LANDSCAPE WHEEL — MRI ECOSYSTEM (CLUSTERS); FIGURE 30: COMPETITIVE LANDSCAPE MAP – MRI ECOSYSTEM (CLUSTERS & SUBCLUSTERS); FIGURE 31: NORTH AMERICA – MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 32: NORTH AMERICA MRI END-MARKET MIX – ECOSYSTEM REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 33: NORTH AMERICA MRI END-MARKET MIX – SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 34: NORTH AMERICA MRI CLINICAL APPLICATION MIX – ECOSYSTEM REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 35: NORTH AMERICA MRI CLINICAL APPLICATION MIX – SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 36: NORTH AMERICA MRI PURCHASE MODEL – SYSTEMS REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 37: NORTH AMERICA MRI PURCHASE MODEL – SYSTEMS REVENUE SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 38: NORTH AMERICA MRI OPERATING MODEL – SERVICE REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 39: NORTH AMERICA MRI OPERATING MODEL – SERVICE REVENUE SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 40: NORTH AMERICA MRI AI LAYER – AI RECURRING REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 41: NORTH AMERICA MRI AI LAYER – SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 42: US – MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 43: US MRI MARKET STRUCTURE SNAPSHOT – ANALYTICAL CUTS (2024A VS 2035E) - REVENUE ALLOCATIONS BY END-MARKET, CLINICAL APPLICATION, PURCHASE MODEL, OPERATING MODEL, AND AI CAPABILITY CATEGORY; FIGURE 44: CANADA – MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 45: CANADA MRI MARKET STRUCTURE SNAPSHOT – ANALYTICAL CUTS (2024A VS 2035E) - REVENUE ALLOCATIONS BY END-MARKET, CLINICAL APPLICATION, PURCHASE MODEL, OPERATING MODEL, AND AI CAPABILITY CATEGORY; FIGURE 46: EUROPE – MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 47: EUROPE MRI END-MARKET MIX – ECOSYSTEM REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 48: EUROPE MRI END-MARKET MIX – SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 49: EUROPE MRI CLINICAL APPLICATION MIX -- ECOSYSTEM REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 50: EUROPE MRI CLINICAL APPLICATION MIX -- SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 51: EUROPE MRI PURCHASE MODEL – SYSTEMS REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 52: EUROPE MRI PURCHASE MODEL – SYSTEMS REVENUE SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 53: EUROPE MRI OPERATING MODEL – SERVICE REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 54: EUROPE MRI OPERATING MODEL – SERVICE REVENUE SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 55: MRI AI LAYER – EUROPE AI RECURRING REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 56: EUROPE MRI AI LAYER – SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 57: GERMANY – MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 58: GERMANY MRI MARKET STRUCTURE SNAPSHOT – ANALYTICAL CUTS (2024A VS 2035E) - REVENUE ALLOCATIONS BY END-MARKET, CLINICAL APPLICATION, PURCHASE MODEL, OPERATING MODEL, AND AI CAPABILITY CATEGORY; FIGURE 59: FRANCE MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 60: FRANCE MRI MARKET STRUCTURE SNAPSHOT – ANALYTICAL CUTS (2024A VS 2035E) - REVENUE ALLOCATIONS BY END-MARKET, CLINICAL APPLICATION, PURCHASE MODEL, OPERATING MODEL, AND AI CAPABILITY CATEGORY; FIGURE 61: UK MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 62: UK MRI MARKET STRUCTURE SNAPSHOT – ANALYTICAL CUTS (2024A VS 2035E) - REVENUE ALLOCATIONS BY END-MARKET, CLINICAL APPLICATION, PURCHASE MODEL, OPERATING MODEL, AND AI CAPABILITY CATEGORY; FIGURE 63: ITALY MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 64: ITALY MRI MARKET STRUCTURE SNAPSHOT – ANALYTICAL CUTS (2024A VS 2035E) - REVENUE ALLOCATIONS BY END-MARKET, CLINICAL APPLICATION, PURCHASE MODEL, OPERATING MODEL, AND AI CAPABILITY CATEGORY; FIGURE 65: ROE MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 66: ROE MRI MARKET STRUCTURE SNAPSHOT – ANALYTICAL CUTS (2024A VS 2035E) - REVENUE ALLOCATIONS BY END-MARKET, CLINICAL APPLICATION, PURCHASE MODEL, OPERATING MODEL, AND AI CAPABILITY CATEGORY; FIGURE 67: APAC MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 68: APAC MRI END-MARKET MIX – ECOSYSTEM REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 69: APAC MRI END-MARKET MIX – SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 70: APAC MRI CLINICAL APPLICATION MIX -- ECOSYSTEM REVENUE GROWTH BRIDGE (2024A TO 2035E, $ M); FIGURE 71: MRI CLINICAL APPLICATION MIX -- SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 72: APAC MRI PURCHASE MODEL – SYSTEMS REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 73: APAC MRI PURCHASE MODEL – SYSTEMS REVENUE SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 74: APAC MRI OPERATING MODEL – SERVICE REVENUE GROWTH BRIDGE (2024A TO 2035E, $M); FIGURE 75: MRI OPERATING MODEL – SERVICE REVENUE SHARE CHANGE (PP): 2035E VS 2024A; FIGURE 76: CHINA – MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 77: CHINA MRI MARKET STRUCTURE SNAPSHOT – ANALYTICAL CUTS (2024A VS 2035E) - REVENUE ALLOCATIONS BY END-MARKET, CLINICAL APPLICATION, PURCHASE MODEL, OPERATING MODEL, AND AI CAPABILITY CATEGORY; FIGURE 78: JAPAN – MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 79: JAPAN MRI MARKET STRUCTURE SNAPSHOT – ANALYTICAL CUTS (2024A VS 2035E) - REVENUE ALLOCATIONS BY END-MARKET, CLINICAL APPLICATION, PURCHASE MODEL, OPERATING MODEL, AND AI CAPABILITY CATEGORY; FIGURE 80: INDIA – MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 81: INDIA MRI MARKET STRUCTURE SNAPSHOT – ANALYTICAL CUTS (2024A VS 2035E) - REVENUE ALLOCATIONS BY END-MARKET, CLINICAL APPLICATION, PURCHASE MODEL, OPERATING MODEL, AND AI CAPABILITY CATEGORY; FIGURE 82: ROAPAC – MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 83: ROAPAC MRI MARKET STRUCTURE SNAPSHOT – ANALYTICAL CUTS (2024A VS 2035E) - REVENUE ALLOCATIONS BY END-MARKET, CLINICAL APPLICATION, PURCHASE MODEL, OPERATING MODEL, AND AI CAPABILITY CATEGORY; FIGURE 84: LATAM – MRI ECOSYSTEM REVENUE FORECAST (USD $M) – BASE CASE; FIGURE 85: LATAM MRI MARKET STRUCTURE SNAPSHOT – ANALYTICAL CUTS (2024A VS 2035E) - REVENUE ALLOCATIONS BY END-MARKET, CLINICAL APPLICATION, PURCHASE MODEL, OPERATING MODEL, AND AI CAPABILITY CATEGORY; FIGURE 86: MEA MRI MARKET STRUCTURE SNAPSHOT – ANALYTICAL CUTS (2024A VS 2035E) - REVENUE ALLOCATIONS BY END-MARKET, CLINICAL APPLICATION, PURCHASE MODEL, OPERATING MODEL, AND AI CAPABILITY CATEGORY
LIST OF TABLES: TABLE 1: GLOBAL MRI MARKET SNAPSHOT (CORE MODEL) — 2024A VS 2035E; TABLE 2: GLOBAL MRI AI VALUE POOL (BRIDGE) — REVENUE BY STREAM (2024A VS 2035E); TABLE 3: GLOBAL MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 4: GLOBAL MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 5: GLOBAL MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 6: GLOBAL MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 7: GLOBAL END‑MARKET MIX — MRI ECOSYSTEM REVENUE BY PROVIDER SETTING ($M); TABLE 8: GLOBAL MRI ECOSYSTEM REVENUE BY CLINICAL APPLICATION ($M); TABLE 9: GLOBAL PURCHASE MODEL MIX — MRI SYSTEMS BY FINANCING STRUCTURE (UNITS; $M); TABLE 10: GLOBAL OPERATING MODEL MIX — MRI SERVICE REVENUE BY DELIVERY & STAFFING STRUCTURE ($M) + REMOTE SCANNING OVERLAY; TABLE 11: GLOBAL AI LAYER MIX — MRI AI RECURRING REVENUE BY CAPABILITY CATEGORY ($M); TABLE 12: SEGMENT MOMENTUM SNAPSHOT — MRI SYSTEM SEGMENTS (2024A, 2035E, $M, % SHARE, CAGR); TABLE 13: SEGMENT MOMENTUM SNAPSHOT — MRI ECOSYSTEM REVENUE STREAMS (2024A, 2035E, $M, % SHARE, CAGR); TABLE 14: M‑TEM SCORECARD — MRI TECHNOLOGY STACK MATURITY (MARKET-LEVEL SCORING); TABLE 15: T DIC TECHNOLOGY — MRI (ADOPTION STAGE, TIME TO MAINSTREAM, IMPACT, AND GATING FACTORS); TABLE 16: MRI AI USE CASES — DEFINITIONS, ADOPTION/GROWTH POSITIONING, MONETIZATION POSTURE, AND ADOPTION GATING THEMES; TABLE 17: MRI AI USE CASES — DEFINITIONS, ADOPTION/GROWTH POSITIONING, MONETIZATION POSTURE, AND ADOPTION GATING THEMES; TABLE 18: COMPETITIVE DATASET — GROWTH OUTLOOK VS. GTM MATURITY (MRI ECOSYSTEM); TABLE 19: ECOSYSTEM COLLABORATION MATRIX — MRI: PARTNERSHIP ARCHETYPES AND CONTROL PLANE OWNERS; TABLE 20: ECOSYSTEM COLLABORATION PLAYBOOK — MRI (GLOBAL); TABLE 21: MRI AI REVENUE BRIDGE BY STREAM – 2024A, 2035E (GLOBAL, $ MILLION); TABLE 22: GLOBAL MRI SYSTEMS — OEM SHARE BANDS (2024A, GLOBAL); TABLE 23: GLOBAL MRI COMPETITIVE SIGNAL SCORECARD (SELECTED HIGH IMPACT COMPANIES; BANDED); TABLE 24: NORTH AMERICA MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 25: NORTH AMERICA MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 26: NORTH AMERICA MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 27: NORTH AMERICA MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 28: NORTH AMERICA MRI COUNTRY MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 29: NORTH AMERICA MRI COUNTRY MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 30: NORTH AMERICA MRI COUNTRY MIX — ECOSYSTEM REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 31: NORTH AMERICA MRI REVENUE BY END-MARKET (2024A TO 2035E, $M); TABLE 32: NORTH AMERICA MRI REVENUE BY CLINICAL APPLICATION (2024A TO 2035E, $M); TABLE 33: NORTH AMERICA MRI REVENUE BY PURCHASE MODEL (2024A TO 2035E, $M); TABLE 34: NORTH AMERICA MRI REVENUE BY OPERATING MODEL (2024A TO 2035E, $M); TABLE 35: NORTH AMERICA MRI AI LAYER – AI RECURRING REVENUE (2024A TO 2035E, $M); TABLE 36: UNITED STATES MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 37: UNITED STATES MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 38: UNITED STATES MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 39: UNITED STATES MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 40: CANADA MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 41: CANADA MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 42: CANADA MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 43: CANADA MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 44: EUROPE MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 45: EUROPE MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 46: EUROPE MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 47: EUROPE MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END OF YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E167 TABLE 48: EUROPE MRI COUNTRY MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 49: EUROPE MRI COUNTRY MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 50: EUROPE MRI COUNTRY MIX — ECOSYSTEM REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 51: EUROPE MRI REVENUE BY END-MARKET (2024A TO 2035E, $M); TABLE 52: EUROPE MRI REVENUE BY CLINICAL APPLICATION (2024A TO 2035E, $M); TABLE 53: EUROPE MRI REVENUE BY PURCHASE MODEL (2024A TO 2035E, $M); TABLE 54: EUROPE MRI REVENUE BY OPERATING MODEL (2024A TO 2035E, $M); TABLE 55: EUROPE MRI AI LAYER – AI RECURRING REVENUE (2024A TO 2035E, $M); TABLE 56: GERMANY MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 57: GERMANY MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 58: GERMANY MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E); TABLE 59: GERMANY MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 60: FRANCE MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 61: FRANCE MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 62: FRANCE MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 63: FRANCE MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 64: UK MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 65: UK MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 66: UK MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 67: UK MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 68: ITALY MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 69: ITALY MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 70: ITALY MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 71: ITALY MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 72: REST OF EUROPE (ROE) MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 73: REST OF EUROPE (ROE) MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 74: REST OF EUROPE (ROE) MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 75: REST OF EUROPE (ROE) MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 76: APAC MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 77: APAC MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 78: APAC MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 79: APAC MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E 229 TABLE 80: APAC MRI COUNTRY MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 81: APAC MRI COUNTRY MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 82: APAC MRI COUNTRY MIX — ECOSYSTEM REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 83: APAC MRI REVENUE BY END-MARKET (2024A TO 2035E, $M); TABLE 84: APAC MRI REVENUE BY CLINICAL APPLICATION (2024A TO 2035E, $M); TABLE 85: APAC MRI REVENUE BY PURCHASE MODEL (2024A TO 2035E, $M); TABLE 86: APAC MRI REVENUE BY OPERATING MODEL (2024A TO 2035E, $M); TABLE 87: APAC MRI AI LAYER – AI RECURRING REVENUE (2024A TO 2035E, $M); TABLE 88: CHINA MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 89: CHINA MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 90: CHINA MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 91: CHINA MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E 250 TABLE 92: JAPAN MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 93: JAPAN MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 94: MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 95: MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 96: INDIA MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 97: INDIA MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 98: INDIA MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 99: INDIA MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E .269 TABLE 100: ROAPAC MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 101: ROAPAC MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 102: ROAPAC MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 103: ROAPAC MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 104: LATAM MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 105: LATAM MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 106: LATAM MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 107: LATAM MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 108: MEA (MIDDLE EAST & AFRICA) MRI MARKET SUMMARY (2024A, 2035E): UNIT SHIPMENTS, INSTALLED BASE, AND ECOSYSTEM REVENUE BY STREAM ($M); CAGR 2024A–2035E; TABLE 109: MEA (MIDDLE EAST & AFRICA) MRI SYSTEM SEGMENT MIX — UNIT SHIPMENTS (UNITS, 2024A, 2035E); CAGR 2024A–2035E; TABLE 110: MEA (MIDDLE EAST & AFRICA) MRI SYSTEM SEGMENT MIX — SYSTEMS REVENUE ($M, 2024A, 2035E); CAGR 2024A–2035E; TABLE 111: MEA (MIDDLE EAST & AFRICA) MRI SYSTEM SEGMENT MIX — INSTALLED BASE (END‑OF‑YEAR UNITS, 2024A, 2035E); CAGR 2024A–2035E

Search Inside Report

Pricing

Currency Rates

Single User Online Download $4,950
Global Site License Online Download $8,950

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now